Electrophysiology Mapping and Ablation Devices | Market Insights | Asia Pacific (Supplemental) | 2021
The US EP mapping and ablation device market will experience moderate growth through 2030 due to favorable reimbursement for ablation procedures, increasing ablation procedure volumes, and the uptake of premium-priced devices. However, the COVID-19 global pandemic had a significant impact on the US EP mapping and ablation device market, resulting in lost procedure volumes in 2020. The market recovery is expected to begin in the latter half of 2021 continuing into 2022 and the market growth will return to pre-pandemic levels by 2024.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for EP mapping and ablation devices in the US across a 11-year period.
